Financial statements Diagnostyka Oncogene
Balance sheet data of DIAGNOSTYKA ONCOGENE
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|---|---|---|---|---|---|
Total assets | 3 514 962,20 | 5 937 745,31 | 7 357 186,89 | 7 269 384,03 | 8 256 295,72 | 14 631 908,34 |
A. Fixed assets | 383 550,82 | 362 321,20 | 376 846,66 | 808 309,48 | 2 720 831,74 | 2 276 215,43 |
B. Current assets | 3 131 411,38 | 5 575 424,11 | 6 980 340,23 | 6 461 074,55 | 5 535 463,98 | 12 355 692,91 |
C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
Total liabilities | 3 514 962,20 | 5 937 745,31 | 7 357 186,89 | 7 269 384,03 | 8 256 295,72 | 14 631 908,34 |
A. Equity | 3 094 539,65 | 5 149 878,01 | 6 171 618,88 | 6 500 671,41 | 7 092 454,14 | 11 907 459,98 |
B. Liabilities and provisions for liabilities | 420 422,55 | 787 867,30 | 1 185 568,01 | 768 712,62 | 1 163 841,58 | 2 724 448,36 |
I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
II. Short-term liabilities | 420 422,55 | 787 867,30 | 895 568,01 | 602 431,12 | 943 044,15 | 2 402 131,45 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.